Showing results (441-450 of 7,691) with videos related to
Sort By:
Pageof 770
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 16, 2000
Ten-year follow-up of critically ill patients undergoing heart transplantationM Carrier, M White, G Pelletier, et al.The Journal of Rheumatology|November 16, 2001
Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthaseJ P Pelletier, J C Fernandes, D V Jovanovic, et al.Arthritis Care & Research|March 22, 2021
Machine Learning-Based Individualized Survival Prediction Model for Total Knee Replacement in Osteoarthritis: Data From the Osteoarthritis InitiativeAfshin Jamshidi, Jean-Pierre Pelletier, Aurelie Labbe, et al.Annals of the Rheumatic Diseases|July 3, 2008
Hsp90{beta} and p130(cas): novel regulatory factors of MMP-13 expression in human osteoarthritic chondrocytesZ Fan, G Tardif, D Hum, et al.Molecular and Cellular Endocrinology|July 1, 1994
Transcriptional regulation of plasminogen activator inhibitor-1 expression in human synovial fibroblasts by prostaglandin E2: mediation by protein kinase A and role of interleukin-1J A DiBattista, J Martel-Pelletier, N Morin, et al.Clinical and Experimental Rheumatology|March 1, 1992
Proteoglycan structural changes in human rheumatoid articular cartilageJ Martel-Pelletier, J P Pelletier, J M Cloutier, et al.Arthritis and Rheumatism|August 31, 2004
Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblastsGinette Tardif, David Hum, Jean-Pierre Pelletier, et al.The Journal of Rheumatology|May 3, 2006
Licofelone reduces progression of structural changes in a canine model of osteoarthritis under curative conditions: effect on protease expression and activityMaxim Moreau, Christelle Boileau, Johanne Martel-Pelletier, et al.Arthritis Research & Therapy|December 13, 2006
The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating proteinKelitha Maxis, Aline Delalandre, Johanne Martel-Pelletier, et al.Arthritis and Rheumatism|June 30, 2007
The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathwaysChristelle Boileau, Johanne Martel-Pelletier, Hassan Fahmi, et al.Pageof 770